C1632 protects against LPS-induced acute lung injury by regulating AXL-mediated MAPK/NF-κB signaling pathway.
第一作者:
Yanan,Mei
第一单位:
Respiratory Medicine Department, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325027, China; School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.
作者:
医学主题词
动物(Animals);脂多糖类(Lipopolysaccharides);急性肺损伤(Acute Lung Injury);受体蛋白质酪氨酸激酶类(Receptor Protein-Tyrosine Kinases);NF-κB(NF-kappa B);原癌基因蛋白质类(Proto-Oncogene Proteins);小鼠(Mice);男(雄)性(Male);信号传导(Signal Transduction);消炎药(Anti-Inflammatory Agents);人类(Humans);肺(Lung);小鼠, 近交C57BL(Mice, Inbred C57BL);MAP激酶信号系统(MAP Kinase Signaling System);四唑类(Tetrazoles)
DOI
10.1016/j.intimp.2025.114542
PMID
40132459
发布时间
2025-05-14
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



